Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 10000 participants.

Also called NCT03418974

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 10,000 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03418974
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03418974. Non-randomized; no masking; primary purpose treatment. Start 2017-11-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia
Condition
Dyslipidemias
Intervention (Drug)
Pitavastatin
Intervention (Drug)
Atorvastatin
Intervention (Drug)
Rosuvastatin
Lead sponsor
Fudan University (class: other)
Collaborator
Peking University People's Hospital (class: other)
Collaborator
Jiangsu Wanbang Medicine Marketing Co., Ltd. (class: not stated)

Record details

Record id
cardio:ct-nct03418974
Content hash
517d5e0cb4ad186bec3b3b13a2dea16a55cc97b9196a87e8345ccf54389ebfd5